Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.

Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanazaki K, Mori M, Doki Y, Naka T.

Oncotarget. 2018 Aug 31;9(68):32917-32928. doi: 10.18632/oncotarget.25952. eCollection 2018 Aug 31.

2.

Hemolytic Uremic Syndrome: An Increasingly Recognized Public Health Problem.

Murakami T, Akimoto T, Yamazaki T, Yoshizawa H, Okada M, Miki A, Nakagawa S, Ohara K, Sugase T, Masuda T, Kobayashi T, Saito O, Muto S, Nagata D.

Clin Med Insights Case Rep. 2018 Jul 3;11:1179547618785137. doi: 10.1177/1179547618785137. eCollection 2018.

3.

Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Murakami T, Akimoto T, Okada M, Hishida E, Sugase T, Miki A, Kohara M, Yoshizawa H, Masuda T, Kobayashi T, Saito O, Muto S, Nagata D.

Drug Target Insights. 2018 Jun 25;12:1177392818782899. doi: 10.1177/1177392818782899. eCollection 2018.

4.

Histological changes of superficial esophageal squamous cell carcinoma after preoperative chemotherapy.

Sugase T, Makino T, Yamasaki M, Tanaka K, Hashimoto T, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Mano M, Morii E, Mori M, Doki Y.

Esophagus. 2018 Jun 16. doi: 10.1007/s10388-018-0626-8. [Epub ahead of print]

PMID:
29909488
5.

Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell-Mediated Antitumor Immunity By Suppressing PD-L1.

Nakagawa S, Serada S, Kakubari R, Hiramatsu K, Sugase T, Matsuzaki S, Matsuzaki S, Ueda Y, Yoshino K, Ohkawara T, Fujimoto M, Kishimoto T, Kimura T, Naka T.

Mol Cancer Ther. 2018 Sep;17(9):1941-1950. doi: 10.1158/1535-7163.MCT-17-0822. Epub 2018 Jun 11.

PMID:
29891489
6.

SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.

Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Nishida T, Hirota S, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanasaki K, Kishimoto T, Mori M, Doki Y, Naka T.

Gastric Cancer. 2018 Nov;21(6):968-976. doi: 10.1007/s10120-018-0822-1. Epub 2018 Apr 5.

PMID:
29623544
7.

Acquired von Willebrand Syndrome Complicating Nephrotic Syndrome: A Case of a Patient With Membranous Nephropathy.

Sugase T, Akimoto T, Kimura T, Yagisawa T, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2018 Mar 13;11:1179547618763371. doi: 10.1177/1179547618763371. eCollection 2018.

8.

SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.

Sugase T, Takahashi T, Serada S, Fujimoto M, Hiramatsu K, Ohkawara T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Kishimoto T, Mori M, Doki Y, Naka T.

Cancer Res. 2017 Dec 15;77(24):6975-6986. doi: 10.1158/0008-5472.CAN-17-1525. Epub 2017 Oct 17.

PMID:
29042418
9.

Metachronous solitary splenic metastasis arising from early gastric cancer: a case report and literature review.

Namikawa T, Kawanishi Y, Fujisawa K, Munekage E, Munekage M, Sugase T, Maeda H, Kitagawa H, Kumon T, Hiroi M, Kobayashi M, Hanazaki K.

BMC Surg. 2017 Aug 29;17(1):96. doi: 10.1186/s12893-017-0292-0. Review.

10.

Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome.

Okada M, Akimoto T, Kawamata M, Imai T, Hishida E, Kohara M, Miki A, Murakami T, Sugase T, Masuda T, Ono Y, Ueda Y, Saito O, Muto S, Nagata D.

Clin Med Insights Case Rep. 2017 Aug 1;10:1179547617723317. doi: 10.1177/1179547617723317. eCollection 2017.

11.

Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.

Yamamoto M, Takahashi T, Serada S, Sugase T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Naka T, Mori M, Doki Y.

Cancer Sci. 2017 Oct;108(10):2052-2060. doi: 10.1111/cas.13329.

12.

Performing Anticoagulation: A Puzzling Case of Cholesterol Embolization Syndrome.

Igarashi Y, Akimoto T, Kobayashi T, Iwazu Y, Miki T, Otani-Takei N, Imai T, Sugase T, Masuda T, Takeda SI, Muto S, Nagata D.

Clin Med Insights Case Rep. 2017 Feb 17;10:1179547616684649. doi: 10.1177/1179547616684649. eCollection 2017.

13.

Sternocostoclavicular Hyperostosis: An Insufficiently Recognized Clinical Entity.

Sugase T, Akimoto T, Kanazawa H, Kotoda A, Nagata D.

Clin Med Insights Arthritis Musculoskelet Disord. 2017 Apr 6;10:1179544117702877. doi: 10.1177/1179544117702877. eCollection 2017.

14.

Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma.

Harada E, Serada S, Fujimoto M, Takahashi Y, Takahashi T, Hara H, Nakatsuka R, Sugase T, Nishigaki T, Saito Y, Hiramatsu K, Nojima S, Mitsuo R, Ohkawara T, Morii E, Mori M, Doki Y, Kaneda Y, Naka T.

Oncotarget. 2017 Apr 11;8(15):24741-24752. doi: 10.18632/oncotarget.15799.

15.

Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.

Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.

Int J Cancer. 2017 Jun 1;140(11):2608-2621. doi: 10.1002/ijc.30666. Epub 2017 Mar 10.

16.

Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy.

Sugase T, Takahashi T, Ishikawa T, Ichikawa H, Kanda T, Hirota S, Nakajima K, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Takiguchi S, Wakai T, Mori M, Doki Y.

Surg Case Rep. 2016 Dec;2(1):137. Epub 2016 Nov 19.

17.

Acute Kidney Injury Associated with Renal Cell Carcinoma Complicated by Renal Vein and Inferior Vena Cava Involvement.

Sugase T, Akimoto T, Kubo T, Imai T, Otani-Takei N, Miki T, Takeda S, Nukui A, Muto S, Morita T, Nagata D.

Intern Med. 2016;55(17):2447-52. doi: 10.2169/internalmedicine.55.6724. Epub 2016 Sep 1.

18.

Renal Failure Found during the Follow-up of Sarcoidosis: The Relevance of a Delay in the Diagnosis of Concurrent Hypercalcemia.

Hishida E, Masuda T, Akimoto T, Sato R, Wakabayashi N, Miki A, Otani N, Imai T, Sugase T, Takeda S, Muto S, Nagata D.

Intern Med. 2016;55(14):1893-8. doi: 10.2169/internalmedicine.55.6194. Epub 2016 Jul 15.

19.

Subclinical growth of an arteriovenous fistula associated with renal biopsy: a case report.

Murakami T, Takeda S, Kanazawa H, Ugajin A, Kijima S, Nakamura H, Imai T, Sugase T, Horikoshi R, Kobayashi T, Akimoto T, Saito O, Nagata D.

BMC Nephrol. 2016 Jul 12;17(1):81. doi: 10.1186/s12882-016-0289-4.

20.

Clinicopathological Characteristics, Surgery and Survival Outcomes of Patients with Duodenal Gastrointestinal Stromal Tumors.

Sugase T, Takahashi T, Nakajima K, Hirota S, Masuzawa T, Nishida T, Kimura Y, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Takiguchi S, Mori M, Doki Y.

Digestion. 2016;94(1):30-6. doi: 10.1159/000447665. Epub 2016 Jul 13.

PMID:
27403957
21.

Tubulointerstitial Nephritis and Uveitis Syndrome: Are Drugs Offenders or Bystanders?

Kawamata M, Akimoto T, Sugase T, Otani-Takei N, Miki T, Masuda T, Kobayashi T, Takeda S, Muto S, Nagata D.

Clin Med Insights Case Rep. 2016 Mar 16;9:21-4. doi: 10.4137/CCRep.S36862. eCollection 2016.

22.

Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot.

Ohara K, Akimoto T, Miki T, Otani N, Sugase T, Masuda T, Murakami T, Imai T, Takeda S, Ando Y, Muto S, Nagata D.

Clin Med Insights Case Rep. 2015 Nov 15;8:97-100. doi: 10.4137/CCRep.S32121. eCollection 2015.

23.

Hypothermia and hypokalemia in a patient with diabetic ketoacidosis.

Saito O, Saito T, Sugase T, Kusano E, Nagata D.

Saudi J Kidney Dis Transpl. 2015 May-Jun;26(3):580-3. doi: 10.4103/1319-2442.157387.

24.

Henoch-Schönlein purpura complicated with severe gastrointestinal bleeding.

Yamazaki T, Akimoto T, Iwazu Y, Sugase T, Takeshima E, Numata A, Komada T, Yoshizawa H, Otani N, Morishita Y, Saito O, Takemoto F, Muto S, Kusano E, Nagata D.

CEN Case Rep. 2015 May;4(1):106-111. doi: 10.1007/s13730-014-0148-8. Epub 2014 Oct 2.

25.

Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier.

Yamazaki T, Akimoto T, Okuda K, Sugase T, Takeshima E, Numata A, Morishita Y, Iwazu Y, Yoshizawa H, Komada T, Iwazu K, Saito O, Takemoto F, Muto S, Kusano E.

Intern Med. 2014;53(2):115-9. Epub 2012 Mar 1.

26.

Challenges of caring for an advanced chronic kidney disease patient with severe thrombocytopenia.

Akimoto T, Ito C, Kotoda A, Ogura M, Sugase T, Sato R, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2013 Nov 25;6:171-5. doi: 10.4137/CCRep.S13238. eCollection 2013.

27.

Anti-glomerular basement membrane glomerulonephritis complicated by thrombocytopenia.

Miki T, Akimoto T, Sugase T, Numata A, Otani N, Iwazu Y, Takeshima E, Morishita Y, Muto S, Kusano E.

Intern Med. 2012;51(24):3395-9. Epub 2012 Dec 15.

28.

Rituximab Treatment for PR3-ANCA-Positive Membranoproliferative Glomerulonephritis Associated with Adult-Onset Periodic Fever Syndrome.

Hamano Y, Yoshizawa H, Sugase T, Miki T, Ohtani N, Hanawa S, Takeshima E, Morishita Y, Saito O, Takemoto F, Muto S, Yumura W, Kusano E.

Case Rep Nephrol Urol. 2012 Jul;2(2):92-101. doi: 10.1159/000341192. Epub 2012 Jul 11.

29.

Balloon-assisted creation and maturation of an arteriovenous fistula in a patient with small-caliber vasculature.

Kotoda A, Akimoto T, Sugase T, Miyamoto N, Kusano E.

Case Rep Nephrol Urol. 2012 Jan;2(1):65-71. doi: 10.1159/000339501. Epub 2012 Jun 5.

30.

Is there a link between the structural impact of thoracic outlet and the development of central venous stenosis?

Kotoda A, Akimoto T, Sugase T, Yamamoto H, Kusano E.

Med Hypotheses. 2013 Jan;80(1):29-31. doi: 10.1016/j.mehy.2012.09.023. Epub 2012 Oct 23.

PMID:
23098374
31.

Minimal change nephrotic syndrome complicated with malignant ascites in a patient with type II diabetes.

Sugase T, Akimoto T, Iwazu Y, Yamazaki T, Numata A, Takemoto F, Muto S, Kusano E.

Intern Med. 2012;51(14):1885-8. Epub 2012 Jul 15.

32.

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients.

Akimoto T, Shiizaki K, Sugase T, Watanabe Y, Yoshizawa H, Otani N, Numata A, Takeshima E, Yamazaki T, Miki T, Ito C, Pastor JV, Iwazu Y, Saito O, Muto S, Kuro-o M, Kusano E.

Clin Exp Nephrol. 2012 Jun;16(3):442-7. doi: 10.1007/s10157-011-0582-2. Epub 2012 Feb 18.

PMID:
22350461
33.

Central venous stenosis among hemodialysis patients is often not associated with previous central venous catheters.

Kotoda A, Akimoto T, Kato M, Kanazawa H, Nakata M, Sugase T, Ogura M, Ito C, Sugimoto H, Muto S, Kusano E.

ASAIO J. 2011 Sep-Oct;57(5):439-43. doi: 10.1097/MAT.0b013e3182246bf8.

PMID:
21869619
34.

Two cases of renal hypouricemia in which dopamine infusion produced a good recovery from exercise-induced acute kidney injury.

Saito O, Sugase T, Saito T, Akimoto T, Inoue M, Ando Y, Muto S, Kusano E.

Clin Nephrol. 2011 Aug;76(2):83-90.

PMID:
21762638
35.

Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection.

Numata A, Akimoto T, Toshima M, Iwazu Y, Otani N, Miki T, Sugase T, Saito O, Hamano Y, Takemoto F, Ueda Y, Muto S, Kusano E.

Clin Exp Nephrol. 2011 Oct;15(5):769-773. doi: 10.1007/s10157-011-0477-2. Epub 2011 Jun 29.

PMID:
21713374
36.

The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients.

Morishita Y, Hanawa S, Miki T, Sugase T, Sugaya Y, Chinda J, Iimura O, Tsunematsu S, Ishibashi K, Kusano E.

Clin Exp Nephrol. 2011 Jun;15(3):398-404. doi: 10.1007/s10157-010-0398-5. Epub 2011 Jan 15.

PMID:
21234784
37.

A case of cervical cancer-related membranous nephropathy treated with radiation therapy.

Ito C, Akimoto T, Nakazawa E, Komori S, Sugase T, Chinda J, Takahashi H, Ioka T, Muto S, Kusano E.

Intern Med. 2011;50(1):47-51. Epub 2011 Jan 1.

38.

The effects of raloxifene on bone turnover markers and bone mineral density in women on maintenance hemodialysis.

Saito O, Saito T, Asakura S, Sugase T, Ito C, Ando Y, Muto S, Kusano E.

Clin Exp Nephrol. 2011 Feb;15(1):126-31. doi: 10.1007/s10157-010-0366-0. Epub 2010 Nov 11.

PMID:
21069410
39.

Primary sclerosing cholangitis associated with increased peripheral eosinophils and serum IgE.

Shimomura I, Takase Y, Matsumoto S, Kuyama J, Nakajima T, Maeda H, Sugase T, Hata A, Hanada M, Okuno M.

J Gastroenterol. 1996 Oct;31(5):737-41.

PMID:
8887045
40.

Synchronous fluctuation of interleukin-6 and platelet count in cyclic thrombocytopenia and thrombocytosis.

Kuyama J, Take H, Matsumoto S, Nakajima T, Sugase T, Hata A, Hanada M, Nakagawa K.

Intern Med. 1995 Jul;34(7):636-9.

41.

[TSH-secreting fibrous pituitary adenoma showing calcification: a case report].

Sato M, Kanai N, Kanai H, Sugase T, Hanada M, Hayakawa T, Saito Y, Oonishi T, Oda Y, Miyagawa J.

No Shinkei Geka. 1995 Mar;23(3):259-63. Review. Japanese.

PMID:
7700496
42.

A short term suppression and stimulation test for pituitary-adrenal function using intravenous betamethasone and 1-18ACTH.

Moriwaki K, Kawakami F, Itoh Y, Iida S, Nishikawa M, Sugase T.

Med J Osaka Univ. 1978 Sep;29(1-2):127-38. No abstract available.

PMID:
223023
43.

Endocrine function in a case of beta-adrenergic hyperdynamic circulatory state.

Fushimi H, Kobayashi Y, Koyama T, Miyata M, Yamada T, Matsuyuki Y, Sugase T, Shima K, Tarui S.

Endocrinol Jpn. 1976 Oct;23(5):423-8.

44.

Comparison of the changes in plasma human growth hormone (HGH) and immuno-reactive glucagon (IRG) after intravenous and subcutaneous injection of glucagon.

Sugase T, Nonaka K, Yoshida T, Morishita S, Toyoshima H, Tarui S, Shima K.

Endocrinol Jpn. 1976 Jun;23(3):187-93.

45.

[Studies on the responsiveness of human adrenocortical tumors to ACTH the clinical and experimental observations (author's transl)].

Hasegawa K, Moriwaki K, Igarashi T, Sugase T, Kawakami F, Itoh Y, Nishikawa M.

Nihon Naibunpi Gakkai Zasshi. 1975 Sep 20;51(9):749-59. Japanese.

PMID:
182566
46.

Rapid radioimmunoassay for guanosine 3',5'-cyclic monophosphate using tritiated ligand.

Fujimoto M, Mihara S, Okabayashi T, Sugase T, Tarui S.

J Biochem. 1975 Jul;78(1):131-7.

47.

Neonatal changes in the concentration of rat liver cyclic AMP and of serum glucose, free fatty acids, insulin, pancreatic, and total glucagon in man and in the rat.

Blázquez E, Sugase T, Blázquez M, Foá PP.

J Lab Clin Med. 1974 Jun;83(6):957-67. No abstract available.

PMID:
4370701
48.

[Proceedings: Microbioassay of ACTH utilizing the isolated adrenal cell system and protein binding method].

Moriwaki K, Igarashi T, Sugase T, Hasegawa K, Kawakami F.

Nihon Naibunpi Gakkai Zasshi. 1974 Feb 20;50(2):167. Japanese. No abstract available.

PMID:
4375572
50.

Failure of growth hormone to stimulate glucagon secretion.

Farmer RW, Pellizzari ED, Fabre LF Jr, Nonaka K, Sugase T, Foá PP.

Proc Soc Exp Biol Med. 1971 Nov;138(2):491-3. No abstract available.

PMID:
5118458

Supplemental Content

Loading ...
Support Center